Does LANADELUMAB Cause Internal haemorrhage? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Internal haemorrhage have been filed in association with LANADELUMAB (TAKHZYRO). This represents 0.3% of all adverse event reports for LANADELUMAB.
6
Reports of Internal haemorrhage with LANADELUMAB
0.3%
of all LANADELUMAB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Internal haemorrhage From LANADELUMAB?
Of the 6 reports, 1 (16.7%) resulted in death, 6 (100.0%) required hospitalization.
Is Internal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANADELUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does LANADELUMAB Cause?
Hereditary angioedema (1,343)
Product dose omission issue (555)
Weight decreased (361)
Weight increased (353)
Inappropriate schedule of product administration (318)
Product use issue (229)
Covid-19 (225)
Injection site pain (201)
Insurance issue (172)
Drug ineffective (142)
What Other Drugs Cause Internal haemorrhage?
RIVAROXABAN (3,513)
ASPIRIN (1,357)
APIXABAN (699)
ADALIMUMAB (468)
CLOPIDOGREL BISULFATE (382)
WARFARIN (373)
DABIGATRAN ETEXILATE (370)
TREPROSTINIL (215)
AMBRISENTAN (182)
MACITENTAN (162)
Which LANADELUMAB Alternatives Have Lower Internal haemorrhage Risk?
LANADELUMAB vs LANADELUMAB-FLYO
LANADELUMAB vs LANREOTIDE
LANADELUMAB vs LANSOPRAZOLE
LANADELUMAB vs LANTHANUM
LANADELUMAB vs LANTUS